AMENDMENT TO SECURITY AGREEMENTSecurity Agreement • August 11th, 2021 • Interpace Biosciences, Inc. • Surgical & medical instruments & apparatus
Contract Type FiledAugust 11th, 2021 Company IndustryThis Amendment to Security Agreement (this “Amendment”) is made and entered into as of May 10, 2021 (the “Effective Date”) by and between Interpace Biosciences, Inc., a Delaware corporation (the “Grantor”), and Ampersand 2018 Limited Partnership, a Delaware limited partnership in its capacity as collateral agent pursuant to the Notes (as hereinafter defined), as secured party (in such capacity, the “Secured Party”). Capitalized terms used herein but not otherwise defined shall have the respective meanings given to them in the Notes.
AMENDMENT TO SECURITY AGREEMENTSecurity Agreement • May 18th, 2021 • Ampersand 2018 Limited Partnership • Surgical & medical instruments & apparatus
Contract Type FiledMay 18th, 2021 Company IndustryThis Amendment to Security Agreement (this “Amendment”) is made and entered into as of May 10, 2021 (the “Effective Date”) by and between Interpace Biosciences, Inc., a Delaware corporation (the “Grantor”), and Ampersand 2018 Limited Partnership, a Delaware limited partnership in its capacity as collateral agent pursuant to the Notes (as hereinafter defined), as secured party (in such capacity, the “Secured Party”). Capitalized terms used herein but not otherwise defined shall have the respective meanings given to them in the Notes.